Since VEGF is implicated in the malignant transformation and angiogenic behaviour of lung cancer cells and confers drug resistance, anti-VEGF therapy with XN might be a realistic option to prevent lung cancer cells from invading and metastasize and to improve the efficacy of the standard chemotherapy. This evidence concerns the gene VEGFA and lung carcinoma.